Evidence map›Paper›PMID 33764436›Full record

ArticleNucleic acids research2021

Interaction of the NRF2 and p63 transcription factors promotes keratinocyte proliferation in the epidermis.

Svitlana Kurinna, Kristin Seltmann, Andreas L Bachmann, Andreas Schwendimann, Lalitha Thiagarajan, Paulina Hennig, Hans-Dietmar Beer, Maria Rosaria Mollo, Caterina Missero, Sabine Werner

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Release of miR-29 Target Laminin C2 Improves Skin Repair.The American journal of pathology · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Targeting NRF2 to promote epithelial repair.Biochemical Society transactions · 2023
    Review
  14. The dual role of p63 in cancer.Frontiers in oncology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Svitlana KurinnaDivision of Cell Matrix Biology and Regenerative Medicine, FBMH, University of Manchester, M13 9PT, United Kingdom.
Kristin SeltmannDepartment of Biology, Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
Andreas L BachmannDepartment of Biology, Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
Andreas SchwendimannDepartment of Biology, Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
Lalitha ThiagarajanDivision of Cell Matrix Biology and Regenerative Medicine, FBMH, University of Manchester, M13 9PT, United Kingdom.
Paulina HennigDepartment of Dermatology, University Hospital Zurich, 8006 Zurich, Switzerland.
Hans-Dietmar BeerDepartment of Dermatology, University Hospital Zurich, 8006 Zurich, Switzerland.
Maria Rosaria MolloCEINGE Biotecnologie Avanzate, Naples, Italy, University of Naples Federico II, 80131 Naples, Italy.
Caterina MisseroCEINGE Biotecnologie Avanzate, Naples, Italy, University of Naples Federico II, 80131 Naples, Italy.
Sabine WernerDepartment of Biology, Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
ETH Zurich · CHCeinge Biotecnologie Avanzate (Italy) · ITUniversity Hospital of Zurich · CHUniversity of Manchester · GB

Funding

Medical Research Council MR/P009700/1
6 · The paper itself

Abstract

Epigenetic regulation of cell and tissue function requires the coordinated action of transcription factors. However, their combinatorial activities during regeneration remain largely unexplored. Here, we discover an unexpected interaction between the cytoprotective transcription factor NRF2 and p63- a key player in epithelial morphogenesis. Chromatin immunoprecipitation combined with sequencing and reporter assays identifies enhancers and promoters that are simultaneously activated by NRF2 and p63 in human keratinocytes. Modeling of p63 and NRF2 binding to nucleosomal DNA suggests their chromatin-assisted interaction. Pharmacological and genetic activation of NRF2 increases NRF2-p63 binding to enhancers and promotes keratinocyte proliferation, which involves the common NRF2-p63 target cyclin-dependent kinase 12. These results unravel a collaborative function of NRF2 and p63 in the control of epidermal renewal and suggest their combined activation as a strategy to promote repair of human skin and other stratified epithelia.

Indexed as

KeratinocytesSkinAnimalsCell ProliferationCells, CulturedCyclin-Dependent KinasesHumansMiceNF-E2-Related Factor 2Transcription FactorsTumor Suppressor ProteinsCDK12 protein, humanCyclin-Dependent KinasesNFE2L2 protein, humanNF-E2-Related Factor 2TP63 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID33764436
PMCPMC8053124
OpenAlexW3137720540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.